Publications

Journal Article Ahead of print

PubMed: 41264278 DOI: 10.1001/jamaoncol.2025.4736

Zanidatamab in HER2-Positive Metastatic Biliary Tract Cancer: Final Results From HERIZON-BTC-01.

JAMA Oncol

Authors: Shubham Pant, Jia Fan, Do-Youn Oh, Hye Jin Choi, Jin Won Kim, Heung-Moon Chang, Lequn Bao, Hui-Chuan Sun, Teresa Macarulla, Feng Xie, Jean-Phillippe Metges, Jie'er Ying, John Bridgewater, Myung-Ah Lee, Mohamedtaki A Tejani, Emerson Y Chen, Harpreet Wasan, Michel Ducreux, Yuanyuan Bao, Xiaotian Wu, Yi Zhao, Phillip M Garfin, Jonathon Gable, James J Harding

Affiliations

  • MD Anderson Cancer Center, Houston, Texas.
  • Zhongshan Hospital of Fudan University, Shanghai, China.
  • Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Integrated Major in Innovative Medical Science, Seoul National University Graduate School, Seoul, South Korea.
  • Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea.
  • Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, South Korea.
  • Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Hubei Cancer Hospital, Wuhan, China.
  • Vall d'Hebrón University Hospital, Vall d'Hebrón Institute of Oncology, Barcelona, Spain.
  • The Third Affiliated Hospital of the Chinese People's Liberation Army Naval Military Medical University, Shanghai, China.
  • CHRU de Brest - Hôpital Morvan, ARPEGO Network, Brest, France.
  • Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China.
  • University College London Cancer Institute, London, United Kingdom.
  • The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul, South Korea.
  • AdventHealth, Altamonte Springs, Florida.
  • Oregon Health & Science University, Portland.
  • Hammersmith Hospital, Imperial College London, London, United Kingdom.
  • Université Paris-Saclay, Gustave Roussy, Villejuif, France.
  • BeOne Medicines, Beijing, China.
  • Jazz Pharmaceuticals, Philadelphia, Pennsylvania.
  • Jazz Pharmaceuticals, Palo Alto, California.
  • Memorial Sloan Kettering Cancer Center, New York, New York.
  • Weill Cornell Medical College, New York, New York.

MeSH

Biliary Tract Neoplasms, Neoplasms, Biliary Tract